Characteristics associated with polypharmacy in people with type 2 diabetes: the Dutch Diabetes Pearl cohort.

Sabine van OortF RuttersM F Warlé-van HerwaardenM T SchramC D StehouwerC J TackE J AbbinkB H WolffenbuttelM M van der KlauwJ H DeVriesS E SiegelaarE J SijbrandsB ÖzcanH W de ValkB SilviusM A SchroijenI M JazetA J van BallegooijenJ W J BeulensP J EldersCornelis Kramersnull null

Published in: Diabetic medicine : a journal of the British Diabetic Association (2020)

Severe and moderate polypharmacy are prevalent in over half of people with type 2 diabetes in primary care, and even more in academic care. People with polypharmacy are characterized by poorer cardiometabolic status. These results highlight the significance of polypharmacy in type 2 diabetes.

Keyphrases

type diabetes
primary care
adverse drug
glycemic control
cardiovascular disease
healthcare
palliative care
high intensity
early onset
emergency department
adipose tissue
quality improvement
skeletal muscle
weight loss